MSS2026 Speakers

Dan Peer
Laboratory of Precision Nanomedicine, Tel Aviv University
The RNA revolution: from novel vaccines to therapeutic genome editing

Andre Germishuizen
National Bioproducts Institute (NBI)
Commercial-Scale Evaluation of a CIMmultus® Mixed-Mode Monolith for IgG Production

Jacek Lubelski
NanoCell
tLNP as a Novel Gene Therapy Vector to Deliver DNA

Aleš Štrancar
BIA Separations Inc
Beyond the Cohn Process: Novel Approaches to Overcome Bottlenecks in Plasma Fractionation

Manuela Bartolini
Alma Mater Studiorum University of Bologna
Monolith-based Immobilized Enzyme Reactors: Enabling Technologies for Diverse and Evolving Landscapes

Stefano Menegatti
North Carolina State University
Affinity and mixed-mode convective adsorbents for the purification and enrichment of vectors for cell and gene therapies

Thomas Muster
BlueSky Immunotherapies
Interferon-inducing viral vector immunotherapy reprograms tumor immunity and eliminates persistent HPV infection
REGISTER
MSS2026 is about Bridging Science, Innovation and Manufacturing in Bioprocessing and Biopharma. Will you be part of it?
REGISTER HERE

CONNECT WITH US
Help us grow a LinkedIn community of experts working in gene therapies, vaccines, and other biological products. Get event updates, special offers, discounts, and more.
MSS2024 OVERVIEW
Take a look at previous editions and hear what past participants had to say.
GET A MSS2024 OVERVIEW


